ILA — Island Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$123.95m
- AU$116.70m
- AU$0.06m
Annual cashflow statement for Island Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -0.938 | -1.88 | -2.7 | -3.16 | -2.77 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.938 | -1.88 | -2.7 | -3.16 | -2.77 |
| Other Investing Cash Flow Items | 0.077 | 0 | 0 | 0 | 0 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.077 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | -0.202 | 0 | -0.18 | -0.33 | -0.247 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.3 | 0 | -0.18 | 2.79 | 8.36 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.46 | -1.67 | -2.79 | -0.338 | 5.59 |